Please login to the form below
NanoValent promotes Mark Lewis to COO
He will also continue to manage the group’s business operations
UK and US-based NanoValent Pharmaceuticals has promoted Mark Lewis to chief operating officer.
Lewis brings over 30 years of international commercial and operations expertise - gained primarily in the area of oncology - to the role, and first joined the early-stage oncology group in 2015.
He has worked at a number of pharmaceutical firms including Amersham International (now GE), Chiron (now Novartis) and Farmitalia (now Pfizer).
In addition to his pharmaceutical experience, Lewis also spent 10 years as a management consultant, working at Hill & Knowlton and Quintiles.
Most recently, Lewis served as managing director for Europe at SuperGen (now Otsuka Pharmaceutical) between 2006 and 2010, and was senior vice president of Ascalon Inc from 2010 until 2012.
COVID-19 Updates and Daily News
Featured jobs
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
-
SENIOR MEDICAL WRITER
-
Salary TBC
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- Pfizer/BioNTech to develop a booster dose for their COVID-19 vaccine
- AZ/Oxford University vaccine shows 82.4% efficacy with extended dosing schedule
- AZ refutes reports suggesting its COVID-19 vaccine is less effective in the elderly
- bluebird bio posts modest Q4 revenue growth as it continues investigation into troubled LentiGlobin
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- Enabling Patient-Focused Research Through Virtual Clinical Trials
- Innovative Approaches to Managing Mental Health Conditions
- Newcells Biotech secures over £5m for 3D tissue models
- FDA briefing document backs J&J’s one-dose COVID-19 vaccine
- Pfizer/BioNTech vaccine is 94% effective after second dose, major real-world study finds
- Moderna announces plans for COVID-19 variant-specific booster jabs and new production targets
PMHub
IGNIFI
We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...
Latest intelligence
- Integrating competitive intelligence into business development, licensing and M&A strategy
- The advantages of partnering with a competitive intelligence or knowledge management team...
- Reaching patients and HCPs during the pandemic
- COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
- #DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
- Take a look at this infographic showing some of the most notorious clinical trials and medical research in history....
Quick links
Infographics
